MARKET

ABBV

ABBV

Abbvie Inc
NYSE
208.50
+0.64
+0.31%
Pre Market: 207.19 -1.31 -0.63% 04:35 05/14 EDT
OPEN
206.86
PREV CLOSE
207.86
HIGH
209.53
LOW
204.30
VOLUME
457
TURNOVER
--
52 WEEK HIGH
239.13
52 WEEK LOW
171.00
MARKET CAP
368.38B
P/E (TTM)
102.90
1D
5D
1M
3M
1Y
5Y
1D
Assessing AbbVie (ABBV) Valuation After Recent Share Price Pullback And Mixed Performance
Simply Wall St · 11h ago
Ironwood Pharmaceuticals: CFO Resignation Knocks Shares - A Downgrade Is Due
Seeking Alpha · 17h ago
AbbVie Exex Says Obseity Market Continues To Be Underpenetrated
Benzinga · 18h ago
AbbVie Exec Says Open To Combining Obesity Assets
Benzinga · 18h ago
The Zacks Analyst Blog NVIDIA, Mastercard, AbbVie, Waterstone and Precipio
NASDAQ · 1d ago
AbbVie Shareholders Back Directors, Maintain Governance Structure
TipRanks · 1d ago
Top Stock Reports for NVIDIA, Mastercard & AbbVie
NASDAQ · 1d ago
3 Reasons to Buy AbbVie Stock (ABBV) Like There's No Tomorrow
The Motley Fool · 1d ago
More
About ABBV
AbbVie Inc. is a global, diversified research-based biopharmaceutical company. It is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. Its product portfolio includes Immunology, Oncology, Aesthetics, Neuroscience, Eye Care and Other Key Products. Immunology products include rheumatology, dermatology and gastroenterology. Oncology products include Imbruvica, Venclexta/Venclyxto, Elahere and Epkinly. Aesthetics portfolio consists of facial injectables, plastics and regenerative medicine, body contouring, and skincare products. Its Neuroscience products include Botox Therapeutic, Vraylar, Duopa and Duodopa, Ubrelvy, and Qulipta. Eye Care products include Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, Restasis, and other eye care. Other key products include Mavyret/Maviret, Creon, and Linzess/Constella. Its investigational candidate, bretisilocin, is for the treatment of patients with moderate-to-severe major depressive disorder (MDD).

Webull offers AbbVie Inc stock information, including NYSE: ABBV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABBV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ABBV stock methods without spending real money on the virtual paper trading platform.